Floatz logo

Carboplatin

Nephropathy

Ain Shams UniversitySmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Nephropathy cohort.

Asset / SponsorPhaseRating
Enalapril Maleate
Fuling Central Hospital of Chongqing City
Phase 2/3B
Folic Acid
Fuling Central Hospital of Chongqing City
Phase 2/3B
Mitapivat
Agios Pharmaceuticals, Inc.
Phase 2CCC
Omnipaque
University of Colorado, Denver
Phase 1/2CCC
SODIUM P-AMINOHIPPURATE
University of Colorado, Denver
Phase 1/2CCC
CIS-DIAMMINEDICHLOROPLATINUM II
Ain Shams University
D
ETOPOSIDE
Ain Shams University
D

Same molecule, other indications

Carboplatin is also rated in:

lung large cell carcinomaDormant
A
Indicative ·
80 / 100
View asset →
non-small cell squamous lung carcinomaDormant
BBB
Indicative ·
76 / 100
View asset →
primary peritoneal carcinomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →